Management of Indeterminate Biliary Strictures. Indeterminate Biliary Strictures

Similar documents
Endoscopic Management of Biliary Strictures. Sammy Ho, MD Director of Pancreaticobiliary Services and Endoscopic Ultrasound Montefiore Medical Center

Evaluation and Management of Refractory Biliary Stricture. J. David Horwhat, MD, FACG Director of Endoscopy Lancaster Gastroenterology, Inc.

STRICTURES OF THE BILE DUCTS Session No.: 5. Andrea Tringali Digestive Endoscopy Unit Catholic University Rome - Italy

Douglas G. Adler MD. ACG Regional Postgraduate Course - Nashville, TN Copyright 2013 American College of Gastroenterology

Colangitis Esclerosante Primaria: Manejo Clínico y Endoscópico

Approach to the Biliary Stricture

R.Sotoudehmanesh, MD Professor of Gastroenterology Digestive Disease Research Institute Tehran University of Medical Sciences Pancreatobiliary

Primary Sclerosing Cholangitis and Cholestatic liver diseases. Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants

Making ERCP Easy: Tips From A Master

Endoscopic treatment of primary sclerosing cholangitis: Is there something new?

The Endoscopic Management of PSC

Navigating the Biliary Tract with CT & MR: An Imaging Approach to Bile Duct Obstruction

Pictorial review of Benign Biliary tract abnormality on MRCP/MRI Liver with Endoscopic (including splyglass) and Endoscopic Ultrasound correlation

The role of ERCP in chronic pancreatitis

7/11/2017. We re gonna help a lot of people today. Biliary/Pancreatic Endoscopy. AGS July 1-2, Kenneth M. Sigman, MD

Index. Note: Page numbers of article titles are in boldface type.

Cholangiocellular carcinoma. Dr. med. Henrik Csaba Horváth PhD

Tratamiento endoscópico de la CEP. En quien como y cuando?

Biliary Strictures: the Long and the Short of It. Willis Parsons, M.D. Medical Director of GI Lab Northwest Community Hospital Arlington Heights, IL

Index. Note: Page numbers of article titles are in boldface type.

6/17/2016. ERCP in June 26, Kenneth M. Sigman, M.D. Birmingham Gastroenterology Associates

ACG Clinical Guideline: Primary Sclerosing Cholangitis

Overview of PSC Jayant A. Talwalkar, MD, MPH Associate Professor of Medicine Mayo Clinic Rochester, MN

A LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY

EDUCATION PRACTICE. Biliary Stricture and Negative Cytology: What Next? AClinical Scenario. The Dilemma

HANDOUT. Bile Duct Brushing Cytology: A Morphologic and Molecular Approach

Overview of PSC Making the Diagnosis

Hilar cholangiocarcinoma. Frank Wessels, Maarten van Leeuwen, UMCU utrecht

Diagnosis and Management of Primary Sclerosing Cholangitis:

Slide 1. Slide 2. Slide 3 Pancreatic Cancer- Case #1. Endoscopic management of GI malignancy. Endoscopic approaches in GI malignancy- Agenda

Frank Burton Memorial Update on Pancreato-biliary Cancers

CBD stones & strictures (Obstructive jaundice)

Chronic Cholestatic Liver Diseases

Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis

CHOLANGIOCARCINOMA (CCA)

Primary Sclerosing Cholangitis diagnosis, surveillance, and management.

Case 1- B.N. 66 yr old F with PMHx of breast cancer s/ p mastectomy, HTN, DM presented with dysphagia to solids and liquids.

Barrett s Esophagus Burn, Resect, Freeze, or Just Watch Strategies for Evaluation and Surveillance of Barrett s Amitabh Chak, MD OBJECTIVES: NOTES:

Approach hto Indeterminate Biliary Strictures

CASE 01 LA Path Slide Seminar 13 March, 08. Deepti Dhall, MD Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center

Biliary Tract Neoplasia: A Cyto-histologic Review. Michelle Reid, MD, MSc Professor of Pathology Director of Cytopathology Emory University Hospital

Management of Patients with Suspected Cholangiocarcinoma CLINICAL GUIDELINES

Latest PSC Research. Joseph A Odin, MD, PhD

Identification of Cholangiocarcinoma by Using the Spyglass Spyscope System for Peroral Cholangioscopy and Biopsy Collection

GASTROINTESTINAL IMAGING STUDY GUIDE

ORIGINAL PAPERS. R. Insertion of fully covered self-expanding metal stents in benign biliary diseases. ABSTRACT MATERIALS AND METHODS INTRODUCTION

EVALUATION FORM WSGNA 2018 Fall Conference Endoscopy for Malignant and Premalignant Lesions of the GI Tract 10/27/2018

Pediatric PSC A children s tale

Imaging of liver and pancreas

Cholangiocarcinoma: Radiologic evaluation and interventions

Sclerosing diseases of the biliary tree

Interpreting Your Tests

Chronic Pancreatitis: When to Scope? Gregory A. Cote, MD, MS Assistant Professor of Medicine Indiana University School of Medicine

Biliary tree dilation - and now what?

ERCP in altered anatomy. Lars Aabakken Oslo University Hospital - Rikshospitalet Oslo, Norway

Asia Pacific Consensus Guidelines for Endoscopic Management of Benign Biliary Strictures

The Use of Pancreatoscopy in the Diagnosis of Intraductal Papillary Mucinous Tumor Lesions of the Pancreas

Having a Stent Placed at ERCP

CME Article Clinics in diagnostic imaging (115) Wai C T, Seto K Y, Sutedja D S

Interventional Radiology in Liver Cancer. Nakarin Inmutto MD

Diagnosis of tumor extension in biliary carcinoma has. Differential Diagnosis and Treatment of Biliary Strictures

Abstract. Anatomic Pathology / DETECTING PANCREATOBILIARY TRACT MALIGNANCY

Biliary and Pancreatic Endoscopy Stones, Strictures, and IPMN

Title: Insertion of fully covered self-expanding. metal stents in benign biliary diseases. Rev

Novel Optical Research at UPMC

DOWNLOAD OR READ : PRIMARY SCLEROSING CHOLANGITIS PDF EBOOK EPUB MOBI

BILIARY TRACT & PANCREAS, PART II

Best of UEG week 2017 (Pancreas-biliary)

JAUNDICE. Zdeněk Fryšák 3rd Clinic of Internal Medicine Nephrology-Rheumatology-Endocrinology Faculty Hospital Olomouc

Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options

Together, putting patients first

Personal Profile. Name: 劉 XX Gender: Female Age: 53-y/o Past history. Hepatitis B carrier

PANCREATIC PSEUDOCYST DRAINAGE: ENDOSCOPIC APPROACHES & THE NURSING ROLE. PRESENTED BY: Susan DePasquale, CGRN, MSN

Biliary cytolgy and pancreatic endoscopic ultrasound-guided FNA. Leena Krogerus Helsinki, FINLAND

Clinical Study Covered Metal Stenting for Malignant Lower Biliary Stricture with Pancreatic Duct Obstruction: Is Endoscopic Sphincterotomy Needed?

Key Points: Autoimmune Liver Disease: Update for Pathologists from the Hepatologist s Perspective. Jenny Heathcote, MD. University of Toronto

A patient with an unusual congenital anomaly of the pancreaticobiliary tree

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms

40th European Congress of Cytology Liverpool, UK, 2-5 th October 2016

Jaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD

EDUCATION PRACTICE. Primary Sclerosing Cholangitis: Patients With a Rising Alkaline Phosphatase at Annual Follow-up.

Review Article Fully Covered Self-Expandable Metal Stents for Treatment of Both Benign and Malignant Biliary Disorders

Expandable stents in digestive pathology present use in an emergency hospital

Endoscopic Treatment of Luminal Perforations and Leaks

Pancreatico-biliary cytology: a practical approach to diagnosis. Corina Cotoi

Primary Sclerosing Cholangitis. Bibleclass Felix Brunner

Overview. Doumit S. BouHaidar, MD ACG/VGS/ODSGNA Regional Postgraduate Course Copyright American College of Gastroenterology 1

Liver and Pancreatic Case discussion

Principles of ERCP: papilla cannulation, indications/contraindications and risks. Dr. med. Henrik Csaba Horváth PhD

Management of the Mucin Filled Bile Duct. A Complication of Intraductal Papillary Mucinous Tumor of the Pancreas

ERCP and EUS: What s New and What Should We Do?

SMJ Singapore Medical Journal

Advances in Hepato Biliary Pancreatic Endoscopy

Cholangiocarcinoma (Bile Duct Cancer)

MedSurg: Endoscopy Presentation for the Investment Community at DDW. Art Butcher Senior Vice President and President, Endoscopy

ENDOSCOPY IN COMPETITION DIAGNOSTICS. Dr. med. Dirk Hartmann Klinikum Ludwigshafen

ESPEN Congress Brussels Stenting of the esophagus and small bowel. Jean-Marc Dumonceau

Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis

The Pancreas. Basic Anatomy. Endocrine pancreas. Exocrine pancreas. Pancreas vasculature. Islets of Langerhans. Acinar cells Ductal System

Transcription:

Management of Indeterminate Biliary Strictures Professor of Medicine Director of Therapeutic Endoscopy Huntsman Cancer Center University of Utah School of Medicine Indeterminate Biliary Strictures Common in clinical practice PSC is ideal model/testbed for indeterminate biliary strictures Combines inflammatory disease, biliary obstruction, and very real risk of malignancy Page 1 of 10

PSC and Malignancy PSC Strongly associated with cholangiocarcinoma Often diagnosed at an advanced stage Resection or OLTx only curative options PSC also associated with: Gallbladder cancer 3-14% Hepatocellular carcinoma (due to underlying cirrhosis) Razumilava et al Hepatology 2011 Adler s Definition A dominant stricture is the cholangiographic finding of a stricture that stands out amongst all others in a patient with primary sclerosing cholangitis. Pro: Immediately intuitive, universally applicable Con: Subjective Page 2 of 10

Tissue Acquisition in PSC Brushings Routine Cytology FISH Forceps biopsy EUS guided FNA Routine Brushings Three possible results: Positive for malignancy Negative for malignancy Atypical cells (AARGHHH!!!) Brush cytology Sensitivity 30-60% Specificity 90-96% Pro- Cheap, easy, fast Con- May be less than helpful Macken Acta Gast Belg 2000 Page 3 of 10

Atypical Cells A common result on biliary brush cytology in PSC Inflammation can influence cellular appearance Malignancy sometimes difficult to detect May warrant re-sampling or evaluation of stricture in full clinical context ABBS Score Score >4 statistically associated with malignancy Witt, Adler et al Diagnostic Cytopathology 2012 Page 4 of 10

FISH Originally developed to test for urothelial cancer Malignant PB cancers: 80% show aneuloploidy Targets the pericentromeric regions of the chromosomes 3 (CEP 3), 7 (CEP 7), and 17 (CEP 17) as well as the chromosomal band 9p21 (LSI 9p21). Four or more morphologically abnormal cells with two or more chromosomes with polysomy constitutes a positive test. Fourteen or more nuclei with a single gain constitutes a positive test Isolated trisomy 7 is equivocal Huddleston, Lamb, Gopez, Adler, Collins Diagnostic Cytopathology 2012 FISH FISH can detect polysomic cells before other tests In one study, 69% of FISH-Positive patients with PSC ultimately had CCA FISH Polysomy Sensitivity: Specificity 46%:88% FISH Trisomy/Tetrasomy Sensitivity : Specificity 25%: 67% Barr Fritcher AJG 2011, Bangarulingam Hepatology 2011 Page 5 of 10

Cholangiocarcinoma Less than 2% of all cancer diagnoses 1.2/100,000 individuals per year 2/3 of cases in individuals >65 years old Risk factors PSC Chronic parasitic infections Recurrent pyogenic cholangitis Patel T et al Cancer 2002 Cholangioscopy Mother-Baby ERCP scope system Allows direct visualization of biliary tree Allows more targeted brushings and biopsies May facilitate detection of cholangiocarcinoma in PSC Once rarely performed Practice now widespread Page 6 of 10

Cholangioscopy and CCA PSC S/S/PPV/NPV: 75/55/23/92 Non-PSC S/S/PPV/NPV: 100/25/50/100 Overall S/S/PPV/NPV: 86/50/32/93 Liu, Adler Minerva 2014 Page 7 of 10

If cholangiocarcinoma If unresectable Uncovered SEMS If pre-op for resection or OLTx: Plastic stents or PTC only FCSEMS for Benign Indications Post-surgical CCY injury Anastomotic stricture following OLTx Inflammatory Chronic Pancreatitis Stones Intractable bile leaks Extrinsic compression Pseudocysts Pancreatic necrosis Page 8 of 10

Biliary Strictures in CP Typically distal biliary strictures Can mimic pancreatic adenocarcinoma Options Multiple Plastic Stents FCSEMS Surgery* * Look for calcifications around stricture CSEMS for Benign Indications Wagh M et al Dign Ther Endo 2013 23 patients with benign biliary strictures Long term success: 83% Irani et al DDS 2014 145 patients with benign biliary strictures Stricture resolution in 66% of patients Median stent dwell time of 26 weeks 17% complication rate Cholangitis Pancreatitis Migration Page 9 of 10

Conclusions Stricture evaluation changing Cholangioscopy EUS Stricture management changing FCSEMS for benign and malignant strictures FISH testing Page 10 of 10